Michael Johnston
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Vector-borne infectious diseases 4
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Pieter R. Cullis (4 shared papers)Göran Karlsson (2 shared papers)Katarina Edwards (2 shared papers)Sandra K. Klimuk (2 shared papers)Sean C. Semple (2 shared papers)Steve Ansell (1 shared paper)Norbert Maurer (1 shared paper)Esther C. Leng (1 shared paper)
- Journals
- PLoS ONE (4 papers)Emerging Microbes & Infections (3 papers)Frontiers in Immunology (3 papers)Stem Cell Research & Therapy (2 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (2 papers)
- Partner nations
- CanadaSwitzerlandSaudi Arabia
In The Last Decade
Michael Johnston
31 papers receiving 756 citations
Peers
Comparison fields: 5 of 73
- Biomaterials 254
- Drug Discovery 5
- Pharmaceutical Science 53
- Molecular Biology 260
- Genetics 24
Countries citing papers authored by Michael Johnston
This map shows the geographic impact of Michael Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Johnston more than expected).
Fields of papers citing papers by Michael Johnston
This network shows the impact of papers produced by Michael Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Johnston. The network helps show where Michael Johnston may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 130 | |
| 2 | 2007 | 117 | |
| 3 | 2021 | 95 | |
| 4 | 2008 | 83 | |
| 5 | 2015 | 54 | |
| 6 | 2016 | 33 | |
| 7 | 2023 | 31 | |
| 8 | 2009 | 28 | |
| 9 | 2019 | 28 | |
| 10 | 2016 | 22 | |
| 11 | 2023 | 22 | |
| 12 | 2005 | 19 | |
| 13 | 2022 | 19 | |
| 14 | 2011 | 15 | |
| 15 | 2014 | 13 | |
| 16 | 2012 | 12 | |
| 17 | 2017 | 10 | |
| 18 | 2016 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2025 | 7 |
About Michael Johnston
Michael Johnston is a scholar working on Parasitology, Biomaterials, Molecular Biology, Virology and Epidemiology, having authored 34 papers that have together received 793 indexed citations. Recurring topics across this work include Protein purification and stability (7 papers), Nanoparticle-Based Drug Delivery (5 papers), Influenza Virus Research Studies (4 papers), Vector-borne infectious diseases (4 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), RNA Interference and Gene Delivery (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). The work is most often cited by research in Biomaterials (254 citations), Drug Discovery (5 citations), Pharmaceutical Science (53 citations), Molecular Biology (260 citations) and Genetics (24 citations). Michael Johnston has collaborated with scholars based in Canada, Switzerland and Saudi Arabia. Frequent co-authors include Pieter R. Cullis, Göran Karlsson, Katarina Edwards, Sandra K. Klimuk, Sean C. Semple, Steve Ansell, Norbert Maurer, Esther C. Leng, Sabina S. Halappanavar and Dongmei Wu. Their work appears in journals such as PLoS ONE, Emerging Microbes & Infections, Frontiers in Immunology, Stem Cell Research & Therapy and Biochimica et Biophysica Acta (BBA) - Biomembranes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.